From the Desk of the CEO

On August 1, 2026, pharmacy lost another of our trailblazers, Peter Vlasses, former ACPE executive director. As I learned this news, I was reminded that Pete was the 2022 Remington Honor Medalist, earning the profession’s highest honor.

Pharmacists, regardless of practice setting, are well aware of the impact of the 340B program on pharmacy revenue. For student pharmacists and others who may not have encountered this program before, you can get a crash course on the history of the program from its origins in 1992 and how it currently operates at the Health Resources & Service Administration’s (HRSA’s) website.

APhA members consistently identify pharmacy staffing, PBM reform, and payment for pharmacists' services as among the most urgent challenges facing the profession today. While each issue presents unique concerns, all are tied together by the financial realities confronting community pharmacy. In this blog, CEO Michael Hogue shares APhA's approach to advancing policy solutions, supporting pharmacists in the workplace, and creating a stronger foundation for the future of patient care.

As the nation confronts the ongoing substance use disorder and overdose crisis, APhA is continuing to advocate for pharmacists to be recognized as essential members of the care team. In this blog, CEO Michael Hogue reflects on the release of the new National Drug Control Strategy, the lives impacted by addiction, and the critical role pharmacists play in prevention, treatment, recovery, and connecting patients to care.

As policymakers debate major changes to the pharmaceutical supply chain, APhA is taking a deliberate, member driven approach to one of pharmacy’s most complex issues: vertical integration. In this blog, CEO Michael Hogue shares how our members, the House of Delegates, and Board of Trustees are shaping a thoughtful, transparent policy response.